225 related articles for article (PubMed ID: 3500976)
1. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines.
Scott DW; O'Garra A; Warren D; Klaus GG
J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976
[TBL] [Abstract][Full Text] [Related]
2. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
[TBL] [Abstract][Full Text] [Related]
3. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
Udhayakumar V; Kumar L; Subbarao B
J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells.
Pennell CA; Scott DW
Eur J Immunol; 1986 Dec; 16(12):1577-81. PubMed ID: 3493148
[TBL] [Abstract][Full Text] [Related]
5. Role of DNA synthesis in secretion of immunoglobulin from murine B cells stimulated by T cell derived lymphokines.
Simpson LG; Isakson PC
J Immunol; 1986 Sep; 137(6):1797-802. PubMed ID: 3091690
[TBL] [Abstract][Full Text] [Related]
6. Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells.
Lund FE; Solvason NW; Cooke MP; Health AW; Grimaldi JC; Parkhouse RM; Goodnow CC; Howard MC
Eur J Immunol; 1995 May; 25(5):1338-45. PubMed ID: 7774637
[TBL] [Abstract][Full Text] [Related]
7. Regulation of an idiotype+ B cell lymphoma. Effects of antigen and anti-idiotopic antibodies on proliferation and Ig secretion.
Ward RE; McNamara-Ward M; Webb CF; Altman D; Lim PL; Tucker PW; Kohler H
J Immunol; 1988 Jul; 141(1):340-6. PubMed ID: 3259969
[TBL] [Abstract][Full Text] [Related]
8. IL-4 (B cell stimulatory factor 1) overcomes Fc gamma receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction.
Phillips NE; Gravel KA; Tumas K; Parker DC
J Immunol; 1988 Dec; 141(12):4243-9. PubMed ID: 2974056
[TBL] [Abstract][Full Text] [Related]
9. A polyclonal model for B cell tolerance. I. Fc-dependent and Fc-independent induction of nonresponsiveness by pretreatment of normal splenic B cells with anti-Ig.
Warner GL; Scott DW
J Immunol; 1991 Apr; 146(7):2185-91. PubMed ID: 1672346
[TBL] [Abstract][Full Text] [Related]
10. Lymphoma models for B cell activation and tolerance. I. Conditions for the anti-mu-dependent stimulation of growth in NBL, a nude B cell lymphoma.
Ling M; Livnat D; Pillai PS; Scott DW
J Immunol; 1985 Mar; 134(3):1449-54. PubMed ID: 2578509
[TBL] [Abstract][Full Text] [Related]
11. Production of multiple lymphokines by the A20.1 B cell lymphoma after cross-linking of membrane Ig by immobilized anti-Ig.
Justement LB; Kreiger J; Cambier JC
J Immunol; 1989 Aug; 143(3):881-9. PubMed ID: 2663989
[TBL] [Abstract][Full Text] [Related]
12. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
Baluyut AR; Subbarao B
J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924
[TBL] [Abstract][Full Text] [Related]
13. Constitutive production of lymphokines by cloned murine B-cell lymphomas--CH12 B lymphoma produces interleukin-4.
O'Garra A; Barbis D; Harada N; Lee F; Howard M
J Mol Cell Immunol; 1989; 4(3):149-58; discussion 158-9. PubMed ID: 2788429
[TBL] [Abstract][Full Text] [Related]
14. B cells from M167 mu kappa transgenic mice fail to proliferate after stimulation with soluble anti-Ig antibodies. A model for antigen-induced B cell anergy.
Sieckmann DG; Holmes K; Hornbeck P; Martin E; Guelde G; Bondada S; Longo DL; Kenny JJ
J Immunol; 1994 May; 152(10):4873-83. PubMed ID: 8176209
[TBL] [Abstract][Full Text] [Related]
15. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
Muraguchi A; Kehrl JH; Butler JL; Fauci AS
J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
[TBL] [Abstract][Full Text] [Related]
16. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
Tamura GS; McGrath MS; Weissman IL
J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
[TBL] [Abstract][Full Text] [Related]
17. Effects of cyclosporine on responses of murine B cells to T cell-derived lymphokines.
O'Garra A; Warren DJ; Holman M; Popham AM; Sanderson CJ; Klaus GG
J Immunol; 1986 Oct; 137(7):2220-4. PubMed ID: 3489759
[TBL] [Abstract][Full Text] [Related]
18. Growth regulation of the B lymphoma cell line WEHI-231 by anti-immunoglobulin, lipopolysaccharide, and other bacterial products.
Jakway JP; Usinger WR; Gold MR; Mishell RI; DeFranco AL
J Immunol; 1986 Oct; 137(7):2225-31. PubMed ID: 3489760
[TBL] [Abstract][Full Text] [Related]
19. Anergy in immature B lymphocytes. Differential responses to receptor-mediated stimulation and T helper cells.
Chang TL; Capraro G; Kleinman RE; Abbas AK
J Immunol; 1991 Aug; 147(3):750-6. PubMed ID: 1830597
[TBL] [Abstract][Full Text] [Related]
20. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
